These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 815533)

  • 1. Experimental Chagas' disease: protective activity in relation with subcellular fractions of the parasite.
    Segura EL; Paulone I; Cerisola J; Cappa SM
    J Parasitol; 1976 Feb; 62(1):131-3. PubMed ID: 815533
    [No Abstract]   [Full Text] [Related]  

  • 2. Protective immunity and pathology induced by inoculation of mice with different subcellular fractions of Trypanosoma cruzi.
    Ruiz AM; Esteva M; Cabeza Meckert P; Laguens RP; Segura EL
    Acta Trop; 1985 Dec; 42(4):299-309. PubMed ID: 2868632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Experimental Chagas' disease: studies on the stability of a protective antigen.
    Cappa SM; Cantarella AI; Lajmanovich S; Segura ES
    J Parasitol; 1976 Feb; 62(1):130-1. PubMed ID: 815532
    [No Abstract]   [Full Text] [Related]  

  • 4. Plasma membrane origin on Trypanosoma cruzi antigenic determinants in Chagas' disease.
    Carniol C; Neves M; Zingales B; de Araujo PS; Colli W
    Rev Inst Med Trop Sao Paulo; 1982; 24(2):83-7. PubMed ID: 6182595
    [No Abstract]   [Full Text] [Related]  

  • 5. [Immune response to Trypanosoma cruzi. An approach to the pathogenesis of Chagas' disease].
    Braun M; de Titto E
    Acta Physiol Pharmacol Latinoam; 1985; 35(1):1-47. PubMed ID: 2932884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The immunology of experimental Chagas' disease. I. Preparation of Trypanosoma cruzi antigens and humoral antibody response to there antigens.
    Teixeira AR; Santos-Buch CA
    J Immunol; 1974 Sep; 113(3):859-69. PubMed ID: 4213449
    [No Abstract]   [Full Text] [Related]  

  • 7. Trypanosoma cruzi proteins which are antigenic during human infections are located in defined regions of the parasite.
    Souto-Padrón T; Reyes MB; Leguizamon S; Campetella OE; Frasch AC; de Souza W
    Eur J Cell Biol; 1989 Dec; 50(2):272-8. PubMed ID: 2516802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trypanosoma cruzi calreticulin: a possible role in Chagas' disease autoimmunity.
    Ribeiro CH; López NC; Ramírez GA; Valck CE; Molina MC; Aguilar L; Rodríguez M; Maldonado I; Martínez R; González C; Troncoso R; Lavandero S; Gingras AR; Schwaeble W; Ferreira A
    Mol Immunol; 2009 Mar; 46(6):1092-9. PubMed ID: 19108895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antigens of subcellular fractions of Trypanosoma cruzi. III. Humoral immune response and histopathology of immunized mice.
    Gonzalez Cappa SM; Bronzina A; Katzin AM; Golfera H; De Martini GW; Segura EL
    J Protozool; 1980 Nov; 27(4):467-71. PubMed ID: 6783746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunology of Chagas' disease I. Circulating antigens in mice experimentally infected with Trypanosoma cruzi.
    Araujo FG
    Rev Inst Med Trop Sao Paulo; 1976; 18(6):433-9. PubMed ID: 828294
    [No Abstract]   [Full Text] [Related]  

  • 11. Efficient protective immunity against Trypanosoma cruzi infection after nasal vaccination with recombinant Sendai virus vector expressing amastigote surface protein-2.
    Duan X; Yonemitsu Y; Chou B; Yoshida K; Tanaka S; Hasegawa M; Tetsutani K; Ishida H; Himeno K; Hisaeda H
    Vaccine; 2009 Oct; 27(44):6154-9. PubMed ID: 19712768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antigens of the subcellular fractions of Trypanosoma cruzi. II. Flagellar and membrane fraction.
    Segura EL; Vazquez C; Bronzina A; Campos JM; Cerisola JA; Cappa SM
    J Protozool; 1977 Nov; 24(4):540-3. PubMed ID: 413914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Macrophages in experimental Chagas' disease.
    Kuhn RE
    Immunol Ser; 1994; 60():495-502. PubMed ID: 8251589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Circulating immune complexes in experimental Chagas' disease. Identification of parasitic antigens in the complexes].
    Chaves J; Ferri RG; Kliemann TA; Irulegui I; de Souza HB
    Rev Inst Med Trop Sao Paulo; 1979; 21(2):77-81. PubMed ID: 113861
    [No Abstract]   [Full Text] [Related]  

  • 15. Identification of novel vaccine candidates for Chagas' disease by immunization with sequential fractions of a trypomastigote cDNA expression library.
    Tekiel V; Alba-Soto CD; González Cappa SM; Postan M; Sánchez DO
    Vaccine; 2009 Feb; 27(9):1323-32. PubMed ID: 19162108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proliferation and bystander suppression induced by membrane and flagellar antigens of Trypanosoma cruzi.
    Mosca W; Briceño L
    Invest Clin; 2009 Mar; 50(1):77-87. PubMed ID: 19418729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective effect of Trypanosoma rangeli against infections with a highly virulent strain of Trypanosoma cruzi.
    Zuñiga C; Palau T; Penin P; Gamallo C; de Diego JA
    Trop Med Int Health; 1997 May; 2(5):482-7. PubMed ID: 9217704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trypanosoma cruzi: infectivity and virulence of trypomastigotes incubated with leukocytes and serum from patients with Chagas' disease.
    Mosca W; Briceño L; Velasco J
    Acta Cient Venez; 1992; 43(5):290-4. PubMed ID: 1343741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Exoantigens of Trypanosoma cruzi. Epitopes reactive against immunoglobulins of patients with Chagas' disease].
    Gruppi A; Moretti ER; Basso B; Vottero-Cima E
    Medicina (B Aires); 1988; 48(2):161-6. PubMed ID: 3148093
    [No Abstract]   [Full Text] [Related]  

  • 20. Identification of antigens of culture forms of Trypanosoma cruzi and Trypanosoma rangeli recognized by sera from patients with chronic Chagas' disease.
    Grögl M; Kuhn RE
    J Parasitol; 1984 Oct; 70(5):822-4. PubMed ID: 6439848
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.